ALFRED

Definition of 'Open Source AI' Closer to Reality with the Open Source Initiative Facilitating Global Workshop Series to Cap Off Multi-Year Initiative

Retrieved on: 
星期二, 五月 14, 2024
Woman, Alfred P. Sloan Foundation, OSI, AI, All, Organization, Open source, SAN, The Open Source Definition, Medical device

SAN FRANCISCO, May 14, 2024 /PRNewswire-PRWeb/ -- Open Source Initiative (OSI), globally recognized by individuals, companies and public institutions as the authority that defines Open Source, is driving a global multi-stakeholder process to define "Open Source AI." This definition will provide a framework to help AI developers and users determine if an AI system is Open Source or not, meaning that it's available under terms that allow unrestricted rights to use, study, modify and share. There are currently no accepted means by which openness can be validated for AI, yet many organizations are claiming their AI to be "Open Source." Just as the Open Source Definition serves as the globally accepted standard for Open Source software, so will the Open Source AI Definition act as a standard for openness in AI systems and their components.

Key Points: 
  • SAN FRANCISCO, May 14, 2024 /PRNewswire-PRWeb/ -- Open Source Initiative (OSI), globally recognized by individuals, companies and public institutions as the authority that defines Open Source, is driving a global multi-stakeholder process to define "Open Source AI."
  • There are currently no accepted means by which openness can be validated for AI, yet many organizations are claiming their AI to be "Open Source."
  • Just as the Open Source Definition serves as the globally accepted standard for Open Source software, so will the Open Source AI Definition act as a standard for openness in AI systems and their components.
  • This "Open Source AI Definition Roadshow" is sponsored by the Alfred P. Sloan Foundation , and OSI's sponsors and donors.

CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)

Retrieved on: 
星期二, 三月 19, 2024
College, PI3, Data science, Machine, Deep learning, Therapy, Harvard University, Audit trail, Membrane protein, School, Statistics, Biotechnology, ICR, Electrical engineering, Princeton University, 3D, Dartmouth College, Breast cancer, SAB, Applied science, Drug resistance, Royal, Machine learning, Computer science, Drug discovery, Associate, Royal Society, Intelligence, Research, AKT, Cancer, University, Cancer research, DARPA, Howard Hughes Medical Institute, Drug development, Principal, AstraZeneca, Entrepreneurship, The Institute, Biomarker, Columbia University, Faculty, Saint John's College, Stanford University, Chemical engineering, Medicine, Management

LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and developing transformational medicines, today announces the foundation of its Scientific Advisory Board (SAB) to provide expert insight and guidance to the Company on the optimal application of 3D deep learning, protein design and prediction in real world medicine.

Key Points: 
  • LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and developing transformational medicines, today announces the foundation of its Scientific Advisory Board (SAB) to provide expert insight and guidance to the Company on the optimal application of 3D deep learning, protein design and prediction in real world medicine.
  • This pioneering technology enables CHARM to target and develop treatments for previously hard-to-drug targets in cancer and other therapeutic areas.
  • Laksh Aithani, Co-Founder, Chief Executive Officer and Board Member of CHARM Therapeutics, said: “As CHARM advances its 3D deep learning platform in discovery it’s critical to maintain aligned oversight of our priorities and keep abreast of this emerging field.
  • Founding members of CHARM’s SAB:
    David Baker, Ph.D. is a Scientific Co-Founder at CHARM and Chair of the SAB.

Wilson Sonsini Partner Luke Liss to Be Honored by the Center for Medicare Advocacy

Retrieved on: 
星期二, 二月 27, 2024
Health, Professional Services, Legal, Insurance, Health Insurance, Nursing, Multimedia, DEI, Chambers and Partners, Savoy Hotel, Editorial, The New York Times, Private law, Pro bono, Conference, Elevate, KFF, Partner, Chairperson, Disability, Executive, San Francisco Bay Area, Patient, Health equity, Bloomberg Law, Justice, Social justice, Partnership, Pharmaceutical industry

Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, is pleased to announce that Pro Bono Partner Luke Liss will be honored with the Alfred J. Chiplin, Jr. Social Justice & Advocacy Award from the Center for Medicare Advocacy.

Key Points: 
  • Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, is pleased to announce that Pro Bono Partner Luke Liss will be honored with the Alfred J. Chiplin, Jr. Social Justice & Advocacy Award from the Center for Medicare Advocacy.
  • View the full release here: https://www.businesswire.com/news/home/20240227364528/en/
    “The Center for Medicare Advocacy is delighted to present Luke Liss with the Alfred J. Chiplin, Jr. Award,” said Judy Stein, the Executive Director/Attorney of the Center for Medicare Advocacy, which she founded in 1986.
  • “Similar to Chip, Luke mixes a passion for justice and compassion for people with a determination to use the law to right wrongs.
  • The event brings together leaders from advocacy, policymaking, philanthropy, and academia to discuss strategies for improving access to comprehensive Medicare, promoting health equity, and ensuring quality healthcare.

US FARATHANE ANNOUNCES APPOINTMENT OF DAVE WISKEL AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

Retrieved on: 
星期五, 三月 1, 2024
Engineering, General Motors, Alfred P. Sloan Foundation, Dick Plasman, Accuride Corporation, USF, PLC, Compuware, Ford, Atlas, Enerpac Tool Group, VW, Development, Partner, Partnership, Management

AUBURN HILLS, Mich., March 1, 2024 /PRNewswire/ -- US Farathane, a leading supplier of injection molded, compression molded and extruded products to the global automotive industry, announced the appointment of Dave Wiskel to the position of President and Chief Executive Officer. Wiskel succeeds Andy Greenlee, who has led the company for nearly three decades and grew the business from $20 million in revenue in 1996 to over one billion dollars of revenue today. Greenlee will remain actively involved in US Farathane as Chairman of the Board.

Key Points: 
  • AUBURN HILLS, Mich., March 1, 2024 /PRNewswire/ -- US Farathane, a leading supplier of injection molded, compression molded and extruded products to the global automotive industry, announced the appointment of Dave Wiskel to the position of President and Chief Executive Officer.
  • Before joining US Farathane, Wiskel served as Chief Executive Officer of global automotive manufacturer Plasman for more than 18 years.
  • He led the company's innovative product diversification and multiple strategic acquisitions, vastly expanding its operations across the globe.
  • Henderson spent 26 years with General Motors in several executive management roles, including President and Chief Executive Officer, President and Chief Operating Officer, and Vice Chairman and Chief Financial Officer, and currently sits on several boards including those of Adient, PLC, Marriott International, Inc. and the Alfred P. Sloan Foundation.

The Alfred I. duPont Charitable Trust Names New Directors to The Nemours Foundation Board

Retrieved on: 
星期四, 二月 15, 2024
CFO, Investment, Advisory board, Nemours Foundation, Management, Risk management, Health, Hospital, Growth, UPMC, Risk, Audit committee, University, Software as a service, Nemours Children's Hospital, USAA, Knowledge, Children's Hospital, Insurance, Former

JACKSONVILLE, Fla., Feb. 15, 2024 /PRNewswire/ -- The Alfred I. duPont Charitable Trust, which for almost 90 years has supported and advanced its charitable beneficiary, The Nemours Foundation, today announced the election of three new Directors to The Nemours Foundation Board.

Key Points: 
  • JACKSONVILLE, Fla., Feb. 15, 2024 /PRNewswire/ -- The Alfred I. duPont Charitable Trust, which for almost 90 years has supported and advanced its charitable beneficiary, The Nemours Foundation, today announced the election of three new Directors to The Nemours Foundation Board.
  • Cindy also leads the annual budget process and manages the Finance, Investment, and Audit Committees of the National Board of Directors.
  • Completing his term on The Nemours Foundation Board of Directors is Rick Walsh, Chairman and CEO of the Knob Hill Companies.
  • "Nemours is extremely grateful to Rick for his more than 12 years of service to Nemours Children's as a member of our inaugural Nemours Children's Hospital, Florida, Florida Board of Managers and more recently, The Nemours Foundation Board," said Durden.

The Institutes Griffith Foundation Welcomes New Advisory Council Members, Beth Murphy and Ken Cooley

Retrieved on: 
星期三, 二月 14, 2024
Public Policy, Government, Insurance, State, Local, Consulting, Continuing, Professional Services, Education, Training, Personal injury lawyer, Public policy, Internal audit, EVP, Bell, University, Senate, Advisory Council, Council, JD, Grange Insurance, Employment, Policy, Privacy, National Council, Corporation, Joint, Management

The Institutes Griffith Foundation is pleased to announce the two newest members of its Advisory Council, Beth W. Murphy and Ken Cooley.

Key Points: 
  • The Institutes Griffith Foundation is pleased to announce the two newest members of its Advisory Council, Beth W. Murphy and Ken Cooley.
  • Both Murphy and Cooley will help to advance Griffith’s mission to provide non-partisan, non-advocative education to public policy members.
  • Beth Murphy , as EVP, Chief Legal Officer, and Corporate Secretary at Grange Insurance , leads the Legal, Compliance, Internal Audit, House Counsel, and Corporate Litigation teams.
  • As stated by The Institutes Griffith Foundation Executive Director, Frank Paul Tomasello, “It is a great pleasure to welcome Beth Murphy and Ken Cooley to the Advisory Council.

duPont Charitable Trust Names James S. Hunt Chair of The Nemours Foundation

Retrieved on: 
星期一, 二月 5, 2024
Committee on Finance, MD, FACS, Nursing, Charitable trust, Physician, Nemours Foundation, Trustee, Advancement, Investment, Management, Health, FAAP, Medicine, Insurance, National Association

JACKSONVILLE, Fla., Feb. 5, 2024 /PRNewswire/ -- The Alfred I. duPont Charitable Trust, which for almost 90 years has supported and advanced its charitable beneficiary The Nemours Foundation, today announced the appointment of James S. Hunt as Chair of The Nemours Foundation Board of Directors.

Key Points: 
  • JACKSONVILLE, Fla., Feb. 5, 2024 /PRNewswire/ -- The Alfred I. duPont Charitable Trust, which for almost 90 years has supported and advanced its charitable beneficiary The Nemours Foundation, today announced the appointment of James S. Hunt as Chair of The Nemours Foundation Board of Directors.
  • The Nemours Foundation is the governing body which oversees Nemours Children's Health.
  • Jim joined the board in 2016, serving as Chair of the Finance, Audit and Compliance Committee, and a member of the Advancement and External Affairs Committee.
  • "On behalf of the duPont Charitable Trust, the Trustees and I welcome Jim to this important role and thank Harold for his tremendous leadership, passion and commitment during his tenure as our Chair," said Hugh M. Durden, Chairman, Alfred I. duPont Charitable Trust.

New Tool Reveals Gene Behavior in Bacteria

Retrieved on: 
星期三, 一月 24, 2024
Death, ECG, DNA replication, Alfred P. Sloan Foundation, TRIPS Agreement, Heart, DNA, Ralph, Champaign–Urbana metropolitan area, Publishing, Gene, University, Medicine, Genetics, Environment, Tick, In situ hybridization, Bacteria, NYU, Human, Cell cycle, Disease, NYU Langone Health, Protein, Nature, Doctor of Philosophy, Genome, National Institutes of Health, Messenger, Gene expression, Bangladesh Technical Education Board, Pathogenic bacteria, TRIP, Cell, Vaccine

This is due in part to the ability of bacteria to switch genes on and off as they sense environmental changes, including the presence of drugs.

Key Points: 
  • This is due in part to the ability of bacteria to switch genes on and off as they sense environmental changes, including the presence of drugs.
  • According to the study authors, organisms from bacteria to humans grow as their cells multiply by dividing, with each cell becoming two.
  • Specifically, the research team found that when DNA polymerase arrives at any specific gene, it disrupts the transcription in a way that reveals the state of that gene's regulatory status.
  • Ultimately, they believe that improvements in technology will enable them to dive ever deeper into gene behaviors in different bacterial species.

Actor's latest role: Student in Rutgers Executive MBA Program

Retrieved on: 
星期三, 一月 24, 2024
Museum, Student, Learning, Music, State university system, Heart, Master of Business Administration, MFA, Life, Multimedia, Napster, Fine art, The Big Lebowski, Economics, Education, MBA, Love, Corporate law, Wildling (band), Health, Pharma, Orbit, Rutgers University, Strike, Television, Teaching, Management

NEWARK, N.J., Jan. 24, 2024 /PRNewswire/ -- Being led away in handcuffs isn't the best look for someone in business school – unless, of course, you're Michael Worden.

Key Points: 
  • The first-year student in the Rutgers Executive MBA program has also been caught spying on guests in a seedy motel, participating in an illegal dice game, and fleeing the law across the rooftops of London.
  • He said he hopes to put his Executive MBA – along with his experiences in music publishing – to work in academia, with the goal of teaching in a music industry program.
  • Learn more about the Rutgers Executive MBA Program: The next in-person info session is Feb. 3 in Newark.
  • Worden chose the Rutgers Executive MBA Program for its high rankings and for its director, Farrokh Langdana .

The Lost Women of Science Initiative Announces New Grants and Projects for 2024

Retrieved on: 
星期四, 一月 18, 2024
Archive, Woman, Imperial College London, Research, Alfred P. Sloan Foundation, Database, SAN, Radio, Female, Penguin Random House, Craigslist, Book, Advisory board, Jess Wade

SAN FRANCISCO, Jan. 18, 2024 /PRNewswire/ -- The Lost Women of Science Initiative enters 2024 with new funding that will allow it to continue to produce new episodes of its flagship podcast, Lost Women of Science throughout 2024, as well as develop its educational programs.

Key Points: 
  • SAN FRANCISCO, Jan. 18, 2024 /PRNewswire/ -- The Lost Women of Science Initiative enters 2024 with new funding that will allow it to continue to produce new episodes of its flagship podcast, Lost Women of Science throughout 2024, as well as develop its educational programs.
  • "Lost Women of Science is performing a great service with this critical and engaging reclamation project to set the record straight and give many remarkable women their historic due."
  • Lost Women of Science helps address that need, giving credit where it's due," said Craig Newmark, Founder of Craigslist and Craig Newmark Philanthropies.
  • The Lost Women of Science Initiative is also excited to welcome Anne Wojcicki, co-founder and CEO of personal genomics company 23andMe, and Jess Wade OBE to our Advisory Board.